TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Trial to Test the Efficacy of a Tailored Intensive Smoking Cessation Intervention in Persons With HIV (PWHs)
Brief Summary: The purpose of this study is to determine whether an intensive, eight session behavioral intervention is superior to standard care in achieving abstinence from cigarettes in smokers living with HIV/AIDS.


Options:
A: Arm Label: Experimental App; Type: EXPERIMENTAL; Interventions: Behavioral: Experimental App | Arm Label: Active comparator app; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Active Comparator App | Intervention Type: BEHAVIORAL; Name: Experimental App; Assigned to Arm(s): Experimental App | Intervention Type: BEHAVIORAL; Name: Active Comparator App; Assigned to Arm(s): Active comparator app
B: Arm Label: Intensive behavioral intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Positively Smoke Free | Arm Label: Standard care; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Standard care | Intervention Type: BEHAVIORAL; Name: Positively Smoke Free; Assigned to Arm(s): Intensive behavioral intervention | Intervention Type: BEHAVIORAL; Name: Standard care; Assigned to Arm(s): Standard care
C: Arm Label: Varenicline; Type: EXPERIMENTAL; Interventions: Drug: Varenicline | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Varenicline; Assigned to Arm(s): Varenicline | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
D: Arm Label: Usual Care; Type: ACTIVE_COMPARATOR; Interventions: Other: Usual Care | Arm Label: Tobacco Tactics Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Tobacco Tactics Intervention | Intervention Type: BEHAVIORAL; Name: Tobacco Tactics Intervention; Assigned to Arm(s): Tobacco Tactics Intervention | Intervention Type: OTHER; Name: Usual Care; Assigned to Arm(s): Usual Care

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Trial to Test the Efficacy of a Tailored Intensive Smoking Cessation Intervention in Persons With HIV (PWHs)
Brief Summary: The purpose of this study is to determine whether an intensive, eight session behavioral intervention is superior to standard care in achieving abstinence from cigarettes in smokers living with HIV/AIDS.


Options:
A: Arm Label: Intensive behavioral intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Positively Smoke Free | Arm Label: Standard care; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Standard care | Intervention Type: BEHAVIORAL; Name: Positively Smoke Free; Assigned to Arm(s): Intensive behavioral intervention | Intervention Type: BEHAVIORAL; Name: Standard care; Assigned to Arm(s): Standard care
B: Arm Label: Standard Care; Type: EXPERIMENTAL; Interventions: Behavioral: Standard Care | Arm Label: Motivational Enhancement; Type: EXPERIMENTAL; Interventions: Behavioral: Motivational Enhancement | Intervention Type: BEHAVIORAL; Name: Standard Care; Assigned to Arm(s): Standard Care | Intervention Type: BEHAVIORAL; Name: Motivational Enhancement; Assigned to Arm(s): Motivational Enhancement
C: N/A
D: Arm Label: Hospital phone counseling; Type: EXPERIMENTAL; Interventions: Behavioral: Telephone Counseling | Arm Label: Fax-to-quit; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Fax-to-quit | Intervention Type: BEHAVIORAL; Name: Telephone Counseling; Assigned to Arm(s): Hospital phone counseling | Intervention Type: BEHAVIORAL; Name: Fax-to-quit; Assigned to Arm(s): Fax-to-quit

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Canagliflozin Compared With Placebo in the Treatment of Older Subjects With Type 2 Diabetes Mellitus Inadequately Controlled on Glucose Lowering Therapy
Brief Summary: The purpose of this study is to evaluate the efficacy and safety of 2 different doses of canagliflozin compared with placebo in older patients (55 to 80 years of age) with type 2 diabetes mellitus (T2DM) with inadequate control on their current diabetes treatment regimen.


Options:
A: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: Insulin glargine, Drug: Metformin | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Drug: Glimepiride, Drug: Metformin | Intervention Type: DRUG; Name: Insulin glargine; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Glimepiride; Assigned to Arm(s): 2 | Intervention Type: DRUG; Name: Metformin; Assigned to Arm(s): 1, 2
B: Arm Label: Canagliflozin 100 mg; Type: EXPERIMENTAL; Interventions: Drug: Canagliflozin 100 mg, Drug: Antihyperglycemic agent(s) | Arm Label: Canagliflozin 300 mg; Type: EXPERIMENTAL; Interventions: Drug: Canagliflozin 300 mg, Drug: Antihyperglycemic agent(s) | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Antihyperglycemic agent(s), Drug: Placebo | Intervention Type: DRUG; Name: Canagliflozin 100 mg; Assigned to Arm(s): Canagliflozin 100 mg | Intervention Type: DRUG; Name: Canagliflozin 300 mg; Assigned to Arm(s): Canagliflozin 300 mg | Intervention Type: DRUG; Name: Antihyperglycemic agent(s); Assigned to Arm(s): Canagliflozin 100 mg, Canagliflozin 300 mg, Placebo | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
C: Intervention Type: DRUG; Name: muraglitazar; Assigned to Arm(s): N/A
D: Arm Label: Liraglutide; Type: EXPERIMENTAL; Interventions: Drug: liraglutide | Arm Label: Exenatide; Type: ACTIVE_COMPARATOR; Interventions: Drug: exenatide | Intervention Type: DRUG; Name: liraglutide; Assigned to Arm(s): Liraglutide | Intervention Type: DRUG; Name: exenatide; Assigned to Arm(s): Exenatide

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Canagliflozin Compared With Placebo in the Treatment of Older Subjects With Type 2 Diabetes Mellitus Inadequately Controlled on Glucose Lowering Therapy
Brief Summary: The purpose of this study is to evaluate the efficacy and safety of 2 different doses of canagliflozin compared with placebo in older patients (55 to 80 years of age) with type 2 diabetes mellitus (T2DM) with inadequate control on their current diabetes treatment regimen.


Options:
A: Arm Label: Anagliptin; Type: ACTIVE_COMPARATOR; Interventions: Drug: Anagliptin | Arm Label: Sitagliptin; Type: ACTIVE_COMPARATOR; Interventions: Drug: Sitagliptin | Intervention Type: DRUG; Name: Anagliptin; Assigned to Arm(s): Anagliptin | Intervention Type: DRUG; Name: Sitagliptin; Assigned to Arm(s): Sitagliptin
B: Arm Label: Linagliptin; Type: ACTIVE_COMPARATOR; Interventions: Drug: Linagliptin | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Linagliptin; Assigned to Arm(s): Linagliptin | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
C: Arm Label: Albiglutide; Type: EXPERIMENTAL; Interventions: Biological: Albiglutide 30 mg, Biological: Albiglutide 50 mg | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Biological: Albiglutide matching placebo | Intervention Type: BIOLOGICAL; Name: Albiglutide 30 mg; Assigned to Arm(s): Albiglutide | Intervention Type: BIOLOGICAL; Name: Albiglutide 50 mg; Assigned to Arm(s): Albiglutide | Intervention Type: BIOLOGICAL; Name: Albiglutide matching placebo; Assigned to Arm(s): Placebo
D: Arm Label: Canagliflozin 100 mg; Type: EXPERIMENTAL; Interventions: Drug: Canagliflozin 100 mg, Drug: Antihyperglycemic agent(s) | Arm Label: Canagliflozin 300 mg; Type: EXPERIMENTAL; Interventions: Drug: Canagliflozin 300 mg, Drug: Antihyperglycemic agent(s) | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Antihyperglycemic agent(s), Drug: Placebo | Intervention Type: DRUG; Name: Canagliflozin 100 mg; Assigned to Arm(s): Canagliflozin 100 mg | Intervention Type: DRUG; Name: Canagliflozin 300 mg; Assigned to Arm(s): Canagliflozin 300 mg | Intervention Type: DRUG; Name: Antihyperglycemic agent(s); Assigned to Arm(s): Canagliflozin 100 mg, Canagliflozin 300 mg, Placebo | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized, Double-Blind, Placebo and Active-Controlled, 4-Arm, Parallel Group, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Canagliflozin in the Treatment of Subjects With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin Monotherapy
Brief Summary: The purpose of this study is to evaluate the efficacy and safety of canagliflozin compared with sitagliptin and placebo in patients with type 2 diabetes mellitus who are receiving treatment with metformin monotherapy (i.e., treatment with a single drug) and have inadequate glycemic (blood sugar) control.


Options:
A: Arm Label: Liraglutide; Type: EXPERIMENTAL; Interventions: Drug: liraglutide, Drug: placebo | Arm Label: Glibenclamide; Type: ACTIVE_COMPARATOR; Interventions: Drug: glibenclamide, Drug: placebo | Intervention Type: DRUG; Name: liraglutide; Assigned to Arm(s): Liraglutide | Intervention Type: DRUG; Name: glibenclamide; Assigned to Arm(s): Glibenclamide | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): Glibenclamide | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): Liraglutide
B: Arm Label: Pioglitazone QD; Type: EXPERIMENTAL; Interventions: Drug: Pioglitazone | Arm Label: Glyburide QD; Type: ACTIVE_COMPARATOR; Interventions: Drug: Glyburide | Intervention Type: DRUG; Name: Pioglitazone; Assigned to Arm(s): Pioglitazone QD | Intervention Type: DRUG; Name: Glyburide; Assigned to Arm(s): Glyburide QD
C: Arm Label: Canagliflozin 100 mg; Type: EXPERIMENTAL; Interventions: Drug: Canagliflozin | Arm Label: Canagliflozin 300 mg; Type: EXPERIMENTAL; Interventions: Drug: Canagliflozin | Arm Label: Placebo/Sitagliptin; Type: EXPERIMENTAL; Interventions: Drug: Placebo, Drug: Sitagliptin | Intervention Type: DRUG; Name: Canagliflozin; Assigned to Arm(s): Canagliflozin 100 mg, Canagliflozin 300 mg | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo/Sitagliptin | Intervention Type: DRUG; Name: Sitagliptin; Assigned to Arm(s): Placebo/Sitagliptin
D: Arm Label: Canagliflozin 100 mg; Type: EXPERIMENTAL; Interventions: Drug: Canagliflozin, Drug: Metformin immediate release | Arm Label: Canagliflozin 300 mg; Type: EXPERIMENTAL; Interventions: Drug: Canagliflozin, Drug: Metformin immediate release | Arm Label: Sitagliptin 100 mg; Type: ACTIVE_COMPARATOR; Interventions: Drug: Sitagliptin, Drug: Metformin immediate release | Arm Label: Placebo/Sitagliptin; Type: OTHER; Interventions: Drug: Placebo, Drug: Sitagliptin, Drug: Metformin immediate release | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo/Sitagliptin | Intervention Type: DRUG; Name: Canagliflozin; Assigned to Arm(s): Canagliflozin 100 mg, Canagliflozin 300 mg | Intervention Type: DRUG; Name: Sitagliptin; Assigned to Arm(s): Placebo/Sitagliptin, Sitagliptin 100 mg | Intervention Type: DRUG; Name: Metformin immediate release; Assigned to Arm(s): Canagliflozin 100 mg, Canagliflozin 300 mg, Placebo/Sitagliptin, Sitagliptin 100 mg

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Progressive Resistance Training vs. Relaxation for Breast Cancer Patients During Chemotherapy: A Randomized Controlled Intervention Trial to Evaluate the Biological Mechanisms and Effects of Resistance Training on Fatigue and Quality of Life
Brief Summary: The purpose of this randomized intervention study is to investigate the effects and biological mechanisms of a supervised 12-week progressive resistance training on fatigue and quality of life in breast cancer patients during chemotherapy. To determine the effect of the exercise itself beyond potential psychosocial effects due to attention by trainers or the group support, patients in the control group have a comparable training schedule (i.e. 60 min, twice a week, for 12 weeks) but with relaxation training (Jacobsen method).


Options:
A: Arm Label: Resistance training; Type: ACTIVE_COMPARATOR; Interventions: Other: Supervised progressive resistance training | Arm Label: Relaxation training; Type: ACTIVE_COMPARATOR; Interventions: Other: Supervised progressive muscle relaxation training (Jacobsen method) | Intervention Type: OTHER; Name: Supervised progressive resistance training; Assigned to Arm(s): Resistance training | Intervention Type: OTHER; Name: Supervised progressive muscle relaxation training (Jacobsen method); Assigned to Arm(s): Relaxation training
B: Arm Label: Group I (yoga-based rehabilitation program); Type: EXPERIMENTAL; Interventions: Procedure: Quality-of-Life Assessment, Procedure: Yoga | Arm Label: Group II (standard care/control); Type: ACTIVE_COMPARATOR; Interventions: Procedure: Quality-of-Life Assessment, Procedure: Yoga | Intervention Type: PROCEDURE; Name: Quality-of-Life Assessment; Assigned to Arm(s): Group I (yoga-based rehabilitation program), Group II (standard care/control) | Intervention Type: PROCEDURE; Name: Yoga; Assigned to Arm(s): Group I (yoga-based rehabilitation program), Group II (standard care/control)
C: Intervention Type: BEHAVIORAL; Name: Aerobic Exercise Training; Assigned to Arm(s): N/A | Intervention Type: BEHAVIORAL; Name: Resistance Exercise Training; Assigned to Arm(s): N/A
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: CBT and relaxation | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Behavioral: Physical activity | Arm Label: 3; Type: EXPERIMENTAL; Interventions: Behavioral: CBT and physical activity | Arm Label: 4; Type: NO_INTERVENTION; Interventions: Other: Control group | Intervention Type: BEHAVIORAL; Name: CBT and relaxation; Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: Physical activity; Assigned to Arm(s): 2 | Intervention Type: BEHAVIORAL; Name: CBT and physical activity; Assigned to Arm(s): 3 | Intervention Type: OTHER; Name: Control group; Assigned to Arm(s): 4

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effective Care Management of Depressed Diabetes Patients
Brief Summary: Evaluation of telephone care management intervention designed to improve outcomes among depressed diabetes patients.


Options:
A: Intervention Type: BEHAVIORAL; Name: Endurance training; Assigned to Arm(s): N/A | Intervention Type: BEHAVIORAL; Name: Weight-lifting training; Assigned to Arm(s): N/A
B: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Aerobic exercise | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Low impact exercise | Intervention Type: BEHAVIORAL; Name: Aerobic exercise; Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: Low impact exercise; Assigned to Arm(s): 2
C: Arm Label: Enhanced Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Staged Care Management; Type: EXPERIMENTAL; Interventions: Behavioral: Medication Care Management (MCM), Behavioral: Cognitive-Behavioral Therapy (CBT) | Intervention Type: BEHAVIORAL; Name: Medication Care Management (MCM); Assigned to Arm(s): Staged Care Management | Intervention Type: BEHAVIORAL; Name: Cognitive-Behavioral Therapy (CBT); Assigned to Arm(s): Staged Care Management
D: Arm Label: Usual Care Control; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Usual care | Arm Label: Step Up Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Step Up Wellness Program | Intervention Type: BEHAVIORAL; Name: Step Up Wellness Program; Assigned to Arm(s): Step Up Intervention | Intervention Type: BEHAVIORAL; Name: Usual care; Assigned to Arm(s): Usual Care Control

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effective Care Management of Depressed Diabetes Patients
Brief Summary: Evaluation of telephone care management intervention designed to improve outcomes among depressed diabetes patients.


Options:
A: Arm Label: Enhanced Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Staged Care Management; Type: EXPERIMENTAL; Interventions: Behavioral: Medication Care Management (MCM), Behavioral: Cognitive-Behavioral Therapy (CBT) | Intervention Type: BEHAVIORAL; Name: Medication Care Management (MCM); Assigned to Arm(s): Staged Care Management | Intervention Type: BEHAVIORAL; Name: Cognitive-Behavioral Therapy (CBT); Assigned to Arm(s): Staged Care Management
B: Arm Label: Exercise group; Type: EXPERIMENTAL; Interventions: Behavioral: Exercise group | Arm Label: Usual care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Exercise group; Assigned to Arm(s): Exercise group
C: Arm Label: Enhanced treatment as usual; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Enhanced treatment as usual plus adherence training | Arm Label: CBT-AD; Type: EXPERIMENTAL; Interventions: Behavioral: Enhanced treatment as usual plus CBT-AD | Intervention Type: BEHAVIORAL; Name: Enhanced treatment as usual plus adherence training; Assigned to Arm(s): Enhanced treatment as usual | Intervention Type: BEHAVIORAL; Name: Enhanced treatment as usual plus CBT-AD; Assigned to Arm(s): CBT-AD
D: Arm Label: B; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Treatment as usual | Arm Label: A; Type: EXPERIMENTAL; Interventions: Behavioral: Nurse-led case management | Intervention Type: BEHAVIORAL; Name: Nurse-led case management; Assigned to Arm(s): A | Intervention Type: BEHAVIORAL; Name: Treatment as usual; Assigned to Arm(s): B

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Technology Assisted Intervention for the Treatment and Prevention of Depression
Brief Summary: Investigators are evaluating the use of phone sensor data to estimate behavior, depression and anxiety.


Options:
A: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Walking Exercise | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Behavioral: Walking Exercise | Arm Label: 3; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Control--Resistance Training | Intervention Type: BEHAVIORAL; Name: Walking Exercise; Assigned to Arm(s): 1, 2 | Intervention Type: BEHAVIORAL; Name: Control--Resistance Training; Assigned to Arm(s): 3
B: Arm Label: Mobilyze!; Type: EXPERIMENTAL; Interventions: Behavioral: Mobilyze! | Intervention Type: BEHAVIORAL; Name: Mobilyze!; Assigned to Arm(s): Mobilyze!
C: Arm Label: WalkingPad plus Psychological Intervention - PsyWPad Group; Type: EXPERIMENTAL; Interventions: Behavioral: WalkingPad plus Psychological Intervention - PsyWPad Group | Arm Label: WalkingPad plus Virtual Assistant - CyberWPad Group; Type: EXPERIMENTAL; Interventions: Behavioral: WalkingPad plus Virtual Assistant - CyberWPad Group | Arm Label: Paper WalkingPad group - PaperWPad Group; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: WalkingPad group - Paper WPad Group | Intervention Type: BEHAVIORAL; Name: WalkingPad plus Psychological Intervention - PsyWPad Group; Assigned to Arm(s): WalkingPad plus Psychological Intervention - PsyWPad Group | Intervention Type: BEHAVIORAL; Name: WalkingPad plus Virtual Assistant - CyberWPad Group; Assigned to Arm(s): WalkingPad plus Virtual Assistant - CyberWPad Group | Intervention Type: BEHAVIORAL; Name: WalkingPad group - Paper WPad Group; Assigned to Arm(s): Paper WalkingPad group - PaperWPad Group
D: Arm Label: Home-based exercise intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Home-based exercise intervention | Arm Label: Usual care group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Home-based exercise intervention; Assigned to Arm(s): Home-based exercise intervention

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Clinical Study on the Effect of Remote Ischemic Conditioning on Atrial Fibrillation and Outcome After Coronary Artery Bypass Grafting
Brief Summary: Recent studies indicate that remote ischemic conditioning can protect the heart and other organs during cardiac surgery. The investigators aim to investigate whether such a stimulus can reduce the incidence of atrial fibrillation or other complications following coronary artery bypass surgery.


Options:
A: Arm Label: ExerciseTr; Type: EXPERIMENTAL; Interventions: Behavioral: Exercise training | Arm Label: Remote ischemic preconditioning group; Type: EXPERIMENTAL; Interventions: Procedure: remote ischemic preconditioning | Arm Label: Control patient group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Exercise training; Assigned to Arm(s): ExerciseTr | Intervention Type: PROCEDURE; Name: remote ischemic preconditioning; Assigned to Arm(s): Remote ischemic preconditioning group
B: Arm Label: Remote ischemic preconditioning; Type: ACTIVE_COMPARATOR; Interventions: Procedure: remote ischemic preconditioning | Arm Label: control; Type: PLACEBO_COMPARATOR; Interventions: Procedure: remote ischemic preconditioning | Intervention Type: PROCEDURE; Name: remote ischemic preconditioning; Assigned to Arm(s): Remote ischemic preconditioning, control
C: Arm Label: Remote ischemic preconditioning; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Remote ischemic preconditioning | Arm Label: Control; Type: SHAM_COMPARATOR; Interventions: Procedure: Control | Intervention Type: PROCEDURE; Name: Remote ischemic preconditioning; Assigned to Arm(s): Remote ischemic preconditioning | Intervention Type: PROCEDURE; Name: Control; Assigned to Arm(s): Control
D: Arm Label: Preconditioning; Type: EXPERIMENTAL; Interventions: Procedure: Remote ischemic conditioning | Arm Label: Postconditioning; Type: EXPERIMENTAL; Interventions: Procedure: Remote ischemic conditioning | Arm Label: Pre and postconditioning; Type: EXPERIMENTAL; Interventions: Procedure: Remote ischemic conditioning | Arm Label: Control; Type: SHAM_COMPARATOR; Interventions: Procedure: Sham | Intervention Type: PROCEDURE; Name: Remote ischemic conditioning; Assigned to Arm(s): Postconditioning, Pre and postconditioning, Preconditioning | Intervention Type: PROCEDURE; Name: Sham; Assigned to Arm(s): Control

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized Controlled Trial of Music-Based Multitask Exercises (Jaques-Dalcroze Eurhythmics) on Gait, Balance and Fall Risk in the Elderly
Brief Summary: The aim of this study is to investigate the effectiveness of a 6-month music-based multitask exercises program (Jaques-Dalcroze eurhythmics) in improving gait and balance, and reducing fall risk in community-dwelling older adults with an increased risk of falling.


Options:
A: Arm Label: Physical Activity; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Physical Activity | Arm Label: Successful Aging; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Successful Aging | Intervention Type: BEHAVIORAL; Name: Physical Activity; Assigned to Arm(s): Physical Activity | Intervention Type: BEHAVIORAL; Name: Successful Aging; Assigned to Arm(s): Successful Aging
B: Arm Label: Intervention group; Type: EXPERIMENTAL; Interventions: Other: Music-based multitask exercises program | Arm Label: Delayed intervention control group; Type: OTHER; Interventions: Other: Music-based multitask exercises program | Intervention Type: OTHER; Name: Music-based multitask exercises program; Assigned to Arm(s): Intervention group | Intervention Type: OTHER; Name: Music-based multitask exercises program; Assigned to Arm(s): Delayed intervention control group
C: Intervention Type: PROCEDURE; Name: Falls Prevention Program; Assigned to Arm(s): N/A
D: Arm Label: 1; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Other: Fall prevention exercise program | Intervention Type: OTHER; Name: Fall prevention exercise program; Assigned to Arm(s): 2

Answer: B